Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine.

Richards, Nathan E; Keshavarz, Behnam; Workman, Lisa J; Nelson, Michael R; Platts-Mills, Thomas A E; Wilson, Jeffrey M

Richards, Nathan E; Keshavarz, Behnam; Workman, Lisa J; Nelson, Michael R; Platts-Mills, Thomas A E; Wilson, Jeffrey M.

Richards NE; Division of Allergy and Clinical Immunology, University of Virginia, Charlottesville.
Keshavarz B; Division of Allergy and Clinical Immunology, University of Virginia, Charlottesville.
Workman LJ; Division of Allergy and Clinical Immunology, University of Virginia, Charlottesville.
Nelson MR; Division of Allergy and Clinical Immunology, University of Virginia, Charlottesville.
Platts-Mills TAE; Division of Allergy and Clinical Immunology, University of Virginia, Charlottesville.
Wilson JM; Division of Allergy and Clinical Immunology, University of Virginia, Charlottesville.

JAMA Netw Open ; 4(9): e2124331, 2021 09 01.

Article in English | MEDLINE | ID: covidwho-1391525

Subject(s)

Antibody Formation; COVID-19 Vaccines/immunology; COVID-19/immunology; 2019-nCoV Vaccine mRNA-1273; Adult; Age Factors; BNT162 Vaccine; Female; Humans; Immunoglobulin G/blood; Immunoglobulin G/immunology; Male; Middle Aged; SARS-CoV-2/immunology; Spike Glycoprotein, Coronavirus/blood; Spike Glycoprotein, Coronavirus/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 / Antibody Formation Topics: Vaccines Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: JAMA Netw Open Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google